Adverum Biotechnologies
ADVM
ADVM
48 hedge funds and large institutions have $54.3M invested in Adverum Biotechnologies in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
35% less call options, than puts
Call options by funds: $196K | Put options by funds: $301K
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
74% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 23
Holders
48
Holding in Top 10
3
Calls
$196K
Puts
$301K
Top Buyers
| 1 | +$4.57M | |
| 2 | +$317K | |
| 3 | +$124K | |
| 4 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
+$58K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$48.5K |
Top Sellers
| 1 | -$938K | |
| 2 | -$581K | |
| 3 | -$467K | |
| 4 |
Goldman Sachs
New York
|
-$429K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$276K |
